Hi there,

Immigration raids are spreading across the country. The agencies meant to protect public health are being dismantled from within. Public broadcasting is being defunded... Today, Democracy Now!'s independent reporting is more important than ever. Because we never accept corporate or government funding, we rely on viewers, listeners and readers like you to sustain our work. Can you start a monthly donation? Monthly donors represent more than 20 percent of our annual revenue. Thanks to a group of generous donors, all monthly donations started today will be DOUBLED, which means your $15 gift is worth $30. If you believe that freedom of speech and freedom of the press are essential to the functioning of a democratic society, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

NYC Suing Purdue Pharma & Other Pharmaceutical Companies over Opioid Crisis

HeadlineJan 24, 2018

New York City Mayor Bill de Blasio has announced the city is suing major pharmaceutical manufacturers and distributors over the opioid crisis. Among the companies being sued are Purdue Pharma, which is the maker of OxyContin, and Johnson & Johnson. The opioid crisis killed 64,000 Americans in 2016. Meanwhile, photographer Nan Goldin, who is a recovered opioid addict, and a group of her fellow artists and activists have launched a campaign shaming the secretive Sackler family, which owns Purdue Pharma, over their profiting off the opioid crisis. “I don’t know how they live with themselves,” she said recently.

Topics:
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top